Skip to product information
1 of 1

BT Lab

SKU:BT-MCA1144

SMN1 Monoclonal Antibody

SMN1 Monoclonal Antibody

Regular price $300.00 USD
Regular price Sale price $300.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

This gene is part of a 500 kb inverted duplication on chromosome 5q13. This duplicated region contains at least four genes and repetitive elements which make it prone to rearrangements and deletions. The repetitiveness and complexity of the sequence have also caused difficulty in determining the organization of this genomic region. The telomeric and centromeric copies of this gene are nearly identical and encode the same protein. However, mutations in this gene, the telomeric copy, are associated with spinal muscular atrophy; mutations in the centromeric copy do not lead to disease. The centromeric copy may be a modifier of disease caused by mutation in the telomeric copy. The critical sequence difference between the two genes is a single nucleotide in exon 7, which is thought to be an exon splice enhancer. Note that the nine exons of both the telomeric and centromeric copies are des

Introducing the SMN1 Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of molecular diagnostics. This highly specialized antibody is meticulously engineered to target and detect the survival motor neuron 1 (SMN1) protein, a crucial biomarker associated with spinal muscular atrophy (SMA).

Crafted with utmost precision and utilizing state-of-the-art monoclonal antibody technology, the SMN1 Monoclonal Antibody offers unparalleled specificity and sensitivity in identifying the SMN1 protein. Its exceptional binding affinity ensures accurate and reliable detection, enabling researchers and clinicians to confidently assess the presence and levels of SMN1 protein in various biological samples.

The SMN1 Monoclonal Antibody's exceptional performance is further enhanced by its compatibility with a wide range of applications, including immunohistochemistry, immunofluorescence, and Western blotting. This versatility allows for seamless integration into existing laboratory protocols, facilitating efficient and streamlined workflows.

Moreover, the SMN1 Monoclonal Antibody is meticulously validated through rigorous quality control measures, ensuring consistent and reproducible results. Its robust formulation guarantees long-term stability, enabling researchers to confidently rely on its performance for extended periods.

With its groundbreaking capabilities, the SMN1 Monoclonal Antibody holds immense potential in advancing SMA research and clinical diagnostics. By providing a reliable tool for the accurate detection of SMN1 protein, this innovative product paves the way for improved understanding, early detection, and personalized treatment strategies for SMA patients.

In summary, the SMN1 Monoclonal Antibody represents a breakthrough in molecular diagnostics, offering exceptional specificity, sensitivity, and versatility. With its unparalleled performance and potential impact on SMA research and diagnostics, this product is poised to revolutionize the field and contribute to the advancement of personalized medicine.

View full details